Tumour

Number

Male

Female

Meningioma

25 (47.2%)

7 (28%)

18 (72%)

Glioma

5 (9.4%)

2 (4%)

3 (60%)

Pituitary adenoma

10 (18 .8%)

6 (60%)

4 (40%)

Medulloblastoma

3 (5.7%)

2 (66.67%)

1 (33.33%)

Ependymoma

3 (5.7%)

1 (33.33%)

2 (66.67%)

Metastatic tumour

7 (13.2%)

2 (28.57%)

5 (71.43%)

Total

53 (100%)

20 (37.8%)

33 (62.2%)